4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline
C113H96F4N18O3 — CID 158315303
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline
4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline (PubChem CID 158315303) has the molecular formula C113H96F4N18O3 and a molecular weight of 1830.13 g/mol. Its IUPAC name is 4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline.
Molecular Properties
| Compound Name | 4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline |
|---|---|
| PubChem CID | 158315303 |
| Molecular Formula | C113H96F4N18O3 |
| Molecular Weight | 1830.13 g/mol |
| Exact Mass | 1828.78 |
| IUPAC Name | 4-[6-[2-(3-cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]quinoxaline;4-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;4-[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]morpholine;6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]quinoxaline |
| SMILES | Cc1cc(-c2ncccc2-c2ccc3ncc(N4CCOCC4)n3c2)ccc1F.Cc1cccc(-c2ncccc2-c2ccc3ncc(N4CCOCC4)n3c2)c1.FC(F)(F)c1cccc(-c2ncccc2-c2ccc3nccnc3c2)c1.c1cc(-c2ncccc2-c2ccc3ncc(N4CCOCC4)n3c2)cc(C2CC2)c1.c1cc(-c2ncccc2-c2ccc3nccnc3c2)cc(C2CC2)c1 |
| InChI | InChI=1S/C25H24N4O.C23H21FN4O.C23H22N4O.C22H17N3.C20H12F3N3/c1-3-19(18-6-7-18)15-20(4-1)25-22(5-2-10-26-25)21-8-9-23-27-16-24(29(23)17-21)28-11-13-30-14-12-28;1-16-13-17(4-6-20(16)24)23-19(3-2-8-25-23)18-5-7-21-26-14-22(28(21)15-18)27-9-11-29-12-10-27;1-17-4-2-5-18(14-17)23-20(6-3-9-24-23)19-7-8-21-25-15-22(27(21)16-19)26-10-12-28-13-11-26;1-3-16(15-6-7-15)13-18(4-1)22-19(5-2-10-25-22)17-8-9-20-21(14-17)24-12-11-23-20;21-20(22,23)15-4-1-3-14(11-15)19-16(5-2-8-26-19)13-6-7-17-18(12-13)25-10-9-24-17/h1-5,8-10,15-18H,6-7,11-14H2;2-8,13-15H,9-12H2,1H3;2-9,14-16H,10-13H2,1H3;1-5,8-15H,6-7H2;1-12H |
| InChIKey | GOEOQPHWAHQVAR-UHFFFAOYSA-N |
| XLogP | 23.95 |
| TPSA | 205.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 138 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1830.13 |
| LogP ≤ 5 | 23.95 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158315303 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.